Delivery Order SPE2DB22D2009-SPE2DB25FM1NV
- Not listed
- The Defense Logistics Agency awarded a $2,750.65 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Provocholine Inhalation Solution in 18 mL packs. This is a firm fixed-price contract with a completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a $1,655.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml packaging under contract 4569133382. The award, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract is unset-aside and competitively awarded, with performance to occur at the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine Inhalation Solution in an 18ML pack format. This $25.1K firm fixed-price contract, issued on September 15, 2025, with a completion date of September 16, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18mL pack configuration, valued at $1,100.26 under a firm fixed-price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order represents a purchase of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,068.26 firm-fixed-price contract is for the supply of Provocholine inhalation solution, a medical product used in various healthcare settings. The order has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a large indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
- This federal contract award is a delivery order valued at $4,795.66 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the provision of Provocholine Inhal Soln Pack 18ML. The contract has a non-set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $187,438.32 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed-price contract, which has no set-aside designation, is scheduled for completion by July 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.99 million...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,168.26 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1NVDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award demonstrates AmerisourceBergen's critical role in the federal medical supply chain, particularly in supporting military and veteran healthcare systems through the DLA's pharmaceutical distribution network. The company maintains a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the underlying vehicle enabling the company to supply pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally. Provocholine, a bronchial challenge agent used in pulmonary function testing, represents the type of specialized pharmaceutical product the contractor regularly delivers through its federal contracts to support Defense Health Agency operations and broader government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/17/25 |